The reduction of brain-derived neurotrophic factor (BDNF) affects cognitive function, learning,
and memory and also causes behavioral disorders. Several randomized controlled trials …

Background There is an increased attention to stroke following SARS-CoV-2. The goal of
this study was to better depict the short-term risk of stroke and its associated factors among …

Objective: Coenzyme Q10 is an antioxidant and an essential mitochondrial cofactor which
has been suggested to improve the clinical features of migraine. Several randomized clinical …

Background and Purpose: Stroke is reported as a consequence of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection in several reports. However, data are …

Introduction: Migraine is a disabling neurovascular disorder characterized by increasing levels
of pro-inflammatory cytokines and oxidative stress biomarkers. Curcumin and coenzyme …

Author’s roles Research Project (1): A. Conception (CP-R, HD), B. Organization (CP-R), C.
Execution (HD, PB, AT, LJA, SR-B, AHJ, CP-R). Clinical Assessments (2): A. Design (HD, AT, …

Objective: The prevalence of migraine is higher in patients with gastrointestinal disorders.
Possible underlying mechanisms could be increased intestinal permeability and systemic …

Background Epilepsy is a neurological disorder characterized by the potential to induce
seizure and accompanied by cognitive, psychological, and social consequences. CACNA1A …

Recently, homozygous PUS7 mutations causing premature stop and truncation of the gene
product were identified in 3 independent consanguineous families presenting with …

Background COVID-19 patients with neurological manifestations have poorer outcomes.
We investigated the association between clinicodemographic and laboratory findings with …